Baxter International
North America, Illinois, United States, Deerfield
Description
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.
Investor Profile
Baxter International has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 42% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series D, Series B rounds (top funding stages).
- Majority of deals are located in United States, Ireland, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series C (25%)
- Series D (17%)
- Series B (17%)
- Seed (17%)
- Post Ipo Equity (8%)
- Series A (8%)
- Series Unknown (8%)
Country Focus
- United States (67%)
- Ireland (17%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Canada (8%)
- Austria (8%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Medical Device
- Biopharma
- Pharmaceutical
- Clinical Trials
- Information Services
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
